{"id":429561,"date":"2021-02-04T16:34:03","date_gmt":"2021-02-04T21:34:03","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=429561"},"modified":"2021-02-04T16:34:03","modified_gmt":"2021-02-04T21:34:03","slug":"lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/","title":{"rendered":"Lilly Announces Webcast to Provide Alzheimer&#8217;s Disease Update at AD\/PD Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">INDIANAPOLIS<\/span>, <span class=\"xn-chron\">Feb. 4, 2021<\/span> \/PRNewswire\/ &#8212; Eli Lilly and Company (NYSE: LLY) will conduct a webcast on <span class=\"xn-chron\">Monday, March 15, 2021<\/span> to provide an update on its Alzheimer&#8217;s disease program and discuss results from the Phase 2 TRAILBLAZER-ALZ\u00a0study for donanemab being presented at the 15th International Conference on Alzheimer&#8217;s and Parkinson&#8217;s Diseases (AD\/PD). The webcast will begin at <span class=\"xn-chron\">10:30 a.m. Eastern Time<\/span>.<\/p>\n<p>Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly&#8217;s website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3058912-1&amp;h=3901287377&amp;u=https%3A%2F%2Finvestor.lilly.com%2Fwebcasts-and-presentations&amp;a=https%3A%2F%2Finvestor.lilly.com%2Fwebcasts-and-presentations\" rel=\"nofollow noopener noreferrer\">https:\/\/investor.lilly.com\/webcasts-and-presentations<\/a>. A replay will also be available on the website following the conference call.<\/p>\n<p>\n        <b>About\u00a0Eli Lilly and Company<br \/><\/b>Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3058912-1&amp;h=4105635307&amp;u=http%3A%2F%2Fwww.lilly.com%2F&amp;a=www.lilly.com\" rel=\"nofollow noopener noreferrer\">www.lilly.com<\/a>. \u00a0F-LLY\u00a0\u00a0\u00a0 <\/p>\n<div>\n<table id=\"convertedTable5e51\" cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prnsbt0 prnsbr0 prnbcc prnsbb0 prnsbl0\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Refer to:<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Mark Taylor; <a target=\"_blank\" href=\"mailto:mark.taylor@lilly.com\" class=\"prnews_a\" rel=\"nofollow noopener noreferrer\">mark.taylor@lilly.com<\/a>; (317) 276-5795 (Media)<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prnsbtb0 prnrbrb0 prnvab prnsbtb0 prntar prnpl6 prnsblb0 prnpr6\">\n              \n            <\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Kevin Hern; <a target=\"_blank\" href=\"mailto:hern_kevin_r@lilly.com\" class=\"prnews_a\" rel=\"nofollow noopener noreferrer\">hern_kevin_r@lilly.com<\/a>;\u00a0(317) 277-1838 (Investors)<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder3661\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg\" title=\"Eli Lilly and Company logo. (PRNewsfoto\/Eli Lilly and Company)\" alt=\"Eli Lilly and Company logo. (PRNewsfoto\/Eli Lilly and Company)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DE70857&amp;sd=2021-02-04\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-adpd-conference-301222615.html\">http:\/\/www.prnewswire.com\/news-releases\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-adpd-conference-301222615.html<\/a><\/p>\n<p>SOURCE  Eli Lilly and Company<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DE70857&amp;Transmission_Id=202102041630PR_NEWS_USPR_____DE70857&amp;DateId=20210204\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire INDIANAPOLIS, Feb. 4, 2021 \/PRNewswire\/ &#8212; Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, March 15, 2021 to provide an update on its Alzheimer&#8217;s disease program and discuss results from the Phase 2 TRAILBLAZER-ALZ\u00a0study for donanemab being presented at the 15th International Conference on Alzheimer&#8217;s and Parkinson&#8217;s Diseases (AD\/PD). The webcast will begin at 10:30 a.m. Eastern Time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly&#8217;s website at https:\/\/investor.lilly.com\/webcasts-and-presentations. A replay will also be available on the website following the conference call. About\u00a0Eli Lilly and CompanyLilly is a global healthcare leader that unites caring with discovery to create &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lilly Announces Webcast to Provide Alzheimer&#8217;s Disease Update at AD\/PD Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-429561","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lilly Announces Webcast to Provide Alzheimer&#039;s Disease Update at AD\/PD Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lilly Announces Webcast to Provide Alzheimer&#039;s Disease Update at AD\/PD Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire INDIANAPOLIS, Feb. 4, 2021 \/PRNewswire\/ &#8212; Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, March 15, 2021 to provide an update on its Alzheimer&#8217;s disease program and discuss results from the Phase 2 TRAILBLAZER-ALZ\u00a0study for donanemab being presented at the 15th International Conference on Alzheimer&#8217;s and Parkinson&#8217;s Diseases (AD\/PD). The webcast will begin at 10:30 a.m. Eastern Time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly&#8217;s website at https:\/\/investor.lilly.com\/webcasts-and-presentations. A replay will also be available on the website following the conference call. About\u00a0Eli Lilly and CompanyLilly is a global healthcare leader that unites caring with discovery to create &hellip; Continue reading &quot;Lilly Announces Webcast to Provide Alzheimer&#8217;s Disease Update at AD\/PD Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-04T21:34:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lilly Announces Webcast to Provide Alzheimer&#8217;s Disease Update at AD\\\/PD Conference\",\"datePublished\":\"2021-02-04T21:34:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/\"},\"wordCount\":260,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/458388\\\/Eli_Lilly_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/\",\"name\":\"Lilly Announces Webcast to Provide Alzheimer's Disease Update at AD\\\/PD Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/458388\\\/Eli_Lilly_Logo.jpg\",\"datePublished\":\"2021-02-04T21:34:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/458388\\\/Eli_Lilly_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/458388\\\/Eli_Lilly_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lilly Announces Webcast to Provide Alzheimer&#8217;s Disease Update at AD\\\/PD Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lilly Announces Webcast to Provide Alzheimer's Disease Update at AD\/PD Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/","og_locale":"en_US","og_type":"article","og_title":"Lilly Announces Webcast to Provide Alzheimer's Disease Update at AD\/PD Conference - Market Newsdesk","og_description":"PR Newswire INDIANAPOLIS, Feb. 4, 2021 \/PRNewswire\/ &#8212; Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, March 15, 2021 to provide an update on its Alzheimer&#8217;s disease program and discuss results from the Phase 2 TRAILBLAZER-ALZ\u00a0study for donanemab being presented at the 15th International Conference on Alzheimer&#8217;s and Parkinson&#8217;s Diseases (AD\/PD). The webcast will begin at 10:30 a.m. Eastern Time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly&#8217;s website at https:\/\/investor.lilly.com\/webcasts-and-presentations. A replay will also be available on the website following the conference call. About\u00a0Eli Lilly and CompanyLilly is a global healthcare leader that unites caring with discovery to create &hellip; Continue reading \"Lilly Announces Webcast to Provide Alzheimer&#8217;s Disease Update at AD\/PD Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-04T21:34:03+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lilly Announces Webcast to Provide Alzheimer&#8217;s Disease Update at AD\/PD Conference","datePublished":"2021-02-04T21:34:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/"},"wordCount":260,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/","name":"Lilly Announces Webcast to Provide Alzheimer's Disease Update at AD\/PD Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg","datePublished":"2021-02-04T21:34:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-announces-webcast-to-provide-alzheimers-disease-update-at-ad-pd-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lilly Announces Webcast to Provide Alzheimer&#8217;s Disease Update at AD\/PD Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/429561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=429561"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/429561\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=429561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=429561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=429561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}